Anti-Infective Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anti-Infective Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Inactivated Vaccines Conjugate Vaccines Live/attenuated Vaccines Segment by Application Bacterial Diseases Viral Diseases By Company Emergent BioDefense Operations Lansing Inc. Sanofi Pasteur Merck & Co. MedImmune LLC Novartis Vaccines Diagnostics Ltd. Intercell Biomedical MassBiologics Barr Labs, Inc. Organon Teknika Co. GlaxoSmithKline Biologicals CSL Ltd. ID Biomedical Co. Protein Sciences Co. Wyeth Pharmaceuticals, Inc. Berna Biotech By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
1 Study Coverage 1.1 Anti-Infective Vaccines Product Introduction 1.2 Market by Type 1.2.1 Global Anti-Infective Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Inactivated Vaccines 1.2.3 Conjugate Vaccines 1.2.4 Live/attenuated Vaccines 1.3 Market by Application 1.3.1 Global Anti-Infective Vaccines Market Size Growth Rate by Application, 2017 VS 2021